Literature DB >> 10914317

Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate).

F Zhang1, J W McGinity.   

Abstract

The objectives of this study were to investigate the properties of poly(vinyl acetate) (PVAc) as a retardant polymer and to study the drug release mechanism of theophylline from matrix tablets prepared by hot-melt extrusion. A physical mixture of drug, polymer, and drug release modifiers was fed into the equipment and heated inside the barrel of the extruder. The cylindrical extrudates were either cut into tablets or ground into granules and compressed with other excipients into tablets. Due to the low glass transition temperature of the PVAc, the melt extrusion process was conducted at approximately 70 degrees C. Theophylline was used as the model drug in this study. Theophylline was present in the extrudate in its crystalline form and was released from the tablets by diffusion. The Higuchi diffusion model and percolation theories were applied to the dissolution data to explain the drug release properties of the matrix systems. The release rate was shown to be dependent on the granule size, drug particle size, and drug loading in the tablets. Water-soluble polymers were demonstrated to be efficient release rate modifiers for this system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914317     DOI: 10.1081/ddc-100101320

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  9 in total

1.  Effects of thermal curing conditions on drug release from polyvinyl acetate-polyvinyl pyrrolidone matrices.

Authors:  Hatim S Alkhatib; Saja Hamed; Mohammad K Mohammad; Yasser Bustanji; Bashar Alkhalidi; Khaled M Aiedeh; Samer Najjar
Journal:  AAPS PharmSciTech       Date:  2010-02-20       Impact factor: 3.246

2.  Percolative transport and cluster diffusion near and below the percolation threshold of a porous polymeric matrix.

Authors:  Jayne E Hastedt; James L Wright
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

3.  In vitro release kinetics and physical, chemical and mechanical characterization of a POVIAC®/CaCO3/HAP-200 composite.

Authors:  Javier Aragón; Ramón González; Gastón Fuentes; Luca Palin; Gianluca Croce; Davide Viterbo
Journal:  J Mater Sci Mater Med       Date:  2011-12-27       Impact factor: 3.896

Review 4.  Twin-screw extrusion of sustained-release oral dosage forms and medical implants.

Authors:  Xin Feng; Feng Zhang
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

5.  Chrono modulated multiple unit particulate systems (MUPS) via a continuous hot melt double extrusion technique: Investigation of the formulation and process suitability.

Authors:  Venkata Raman Kallakunta; Sandeep Sarabu; Narendar Dudhipala; Karthik Yadav Janga; Suresh Bandari; Feng Zhang; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2021-08-28       Impact factor: 5.571

Review 6.  Applications of hot-melt extrusion for drug delivery.

Authors:  Michael A Repka; Soumyajit Majumdar; Sunil Kumar Battu; Ramesh Srirangam; Sampada B Upadhye
Journal:  Expert Opin Drug Deliv       Date:  2008-12       Impact factor: 6.648

7.  Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology.

Authors:  Noorullah Naqvi Mohammed; Soumyajit Majumdar; Abhilasha Singh; Weibin Deng; Narasimha S Murthy; Elanor Pinto; Divya Tewari; Thomas Durig; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2012-09-08       Impact factor: 3.246

Review 8.  Continuous twin screw granulation - An advanced alternative granulation technology for use in the pharmaceutical industry.

Authors:  Suresh Bandari; Dinesh Nyavanandi; Venkata Raman Kallakunta; Kartik Yadav Janga; Sandeep Sarabu; Arun Butreddy; Michael A Repka
Journal:  Int J Pharm       Date:  2020-03-16       Impact factor: 5.875

9.  High-Pressure Dielectric Studies-a Way to Experimentally Determine the Solubility of a Drug in the Polymer Matrix at Low Temperatures.

Authors:  Krzysztof Chmiel; Justyna Knapik-Kowalczuk; Ewa Kamińska; Lidia Tajber; Marian Paluch
Journal:  Mol Pharm       Date:  2021-07-11       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.